Daphne Quimi - 14 May 2024 Form 4 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role
Director
Signature
/s/ Joshua B. Cohen, as Attorney in Fact
Issuer symbol
AMLX
Transactions as of
14 May 2024
Net transactions value
+$9,436
Form type
4
Filing time
16 May 2024, 19:37:39 UTC
Previous filing
29 Jun 2023
Next filing
07 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMLX Common Stock Purchase $5,184 +2,750 $1.88 2,750 14 May 2024 Direct
transaction AMLX Common Stock Purchase $4,252 +2,250 +82% $1.89 5,000 15 May 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.